3 results
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
HAS-BLED schemas #Diagnosis ... #Hematology #CHADS2 ... CHADS2VASc #HASBLED #Comparison ... #Score #Risk #Stroke ... Anticoagulation #AFib
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
drinks/week) 1 #CHADS2 ... CHADS2VASc #HASBLED #Comparison ... #Score #Risk #Stroke ... Anticoagulation #AFib ... #Diagnosis #Hematology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
WBCs are usually near-normal ... appropriate only for low risk ... patients with no CV risk ... #hematology #diagnosis ... #management #hematology